Physician

Nabil A Khandker, MD

According to 2025 Medicare claims, Nabil Khandker, MD (NPI: 1871858415) practices epileptologists in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OSU NEUROSCIENCE CENTER LLC (NPI: 1962431817; TIN: 232743545) and primary practice location at 43210-1240. Khandker is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Khandker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 179 traditional Medicare patients, billed 384 HCPCS/CPT codes, and received $27,206 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 2,923 prescription claims across 224 beneficiaries totaling $1,336,950 in drug costs, led by Epidiolex (Cannabidiol (Cbd)). 2020 DME data shows 11 claims. Open Payments data shows 1 records totaling $17. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $150,762 to $1,336,950. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	122	258	$37,460
2018	260	505	$69,894
2019	194	394	$53,125
2020	220	691	$41,498
2021	185	442	$39,711
2022	239	503	$47,431
2023	221	399	$37,191
2024	179	384	$27,206

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	46	224	$150,762
2016	30	209	$179,675
2017	19	98	$20,355
2018	75	621	$253,612
2019	90	863	$363,200
2020	110	1,285	$572,333
2021	140	1,532	$721,648
2022	170	1,808	$979,815
2023	212	2,360	$1,261,763
2024	224	2,923	$1,336,950

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$460
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	44	89	$155
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	26	29	$87
95816	Measurement of brain wave activity (eeg), awake and drowsy	22	22	$42
95819	Measurement of brain wave activity (eeg), awake and asleep	20	20	$42
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	49	61	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Epidiolex	Cannabidiol (Cbd)	42	1,356	$268,286
Aptiom	Eslicarbazepine Acetate	52	1,728	$123,202
Xcopri	Cenobamate	94	2,841	$122,042
Oxtellar Xr	Oxcarbazepine	52	1,483	$77,295
Lamictal	Lamotrigine	42	1,492	$71,801

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$17	CATALYST PHARMACEUTICALS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nabil A. Khandker, MD?

Tedicare shows public-source Medicare data for Nabil A. Khandker, MD (NPI 1871858415), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nabil A. Khandker, MD have ACO affiliation data?

Nabil A. Khandker, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Nabil A. Khandker, MD?

Nabil A. Khandker, MD is linked to OSU NEUROSCIENCE CENTER LLC (billing NPI 1962431817) in the available physician profile data.

Does Nabil A. Khandker, MD have Open Payments data?

Nabil A. Khandker, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.